ContraFect Corporation ContraFect Corporation Nasdaq: CFRX

Navigate ContraFect Corporation

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Lysins
    • Amurins
    • Publications / Posters
    • Video Library
  • Pipeline
    • Overview
    • Exebacase
    • CF-370
    • Gram-negative Lysins
    • Amurins
  • Investors & Media
    • Overview
    • News / Events
    • Presentations
    • Company Information
    • Financial Information
    • Analyst Coverage
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Careers
  • Contact Us

Publications / Posters

Technology

  • Home
  • Technology
  • Publications / Posters
Technology

Technology

  • Overview
  • Lysins
  • Amurins
  • Publications / Posters
  • Video Library
  • « Previous
  • 1
  • 2
  • 3
Efficacy of Single-Dose Lysin CF-301 in Combination with Vancomycin (VAN) or Daptomycin (DAP) in Experimental Endocarditis (IE) Due to Methicillin-Resistant Staphylococcus aureus (MRSA)

Efficacy of Single-Dose Lysin CF-301 in Combination with Vancomycin (VAN) or Daptomycin (DAP) in Experimental Endocarditis (IE) Due to Methicillin-Resistant Staphylococcus aureus (MRSA)

Oral Presentation at ICAAC 2014, September 9
CF-301, a Phage Lysin, is Superior in Combination Therapy to Antistaphylococcal Antibiotics Alone in Murine Staphylococcus aureus Bacteremia

CF-301, a Phage Lysin, is Superior in Combination Therapy to Antistaphylococcal Antibiotics Alone in Murine Staphylococcus aureus Bacteremia

Presented at ICAAC 2013, September 11
CF-301, a Phage Lysin, is a Potent Antimicrobial Agent Against Staphylococcus aureus

CF-301, a Phage Lysin, is a Potent Antimicrobial Agent Against Staphylococcus aureus

Presented at ICAAC 2013, September 11
CF-301, a Phage Lysin, Demonstrates Rapid Bactericidal and Synergistic Activity Against Staphylococcus aureus

CF-301, a Phage Lysin, Demonstrates Rapid Bactericidal and Synergistic Activity Against Staphylococcus aureus

Presented at ICAAC 2013, September 11
CF-301, a Phage Lysin, is a Potent Eradicator of Staphylococcus aureus Biofilms

CF-301, a Phage Lysin, is a Potent Eradicator of Staphylococcus aureus Biofilms

Presented at ICAAC 2013, September 11
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
© 2023 ContraFect Corporation. All Rights Reserved.
Copyright Privacy Policy Expanded Access Policy Disclaimer Site Map
LinkedIn Twitter